Skip to main content

ProShares Ultra Nasdaq Biotechnology

Open-end / ETF
Registrant
ProShares Trust
Class ticker
BIB
Net Assets
$101,351,690
Holdings
264
Latest Report
Aug 31, 2026

Net Assets Over Time

Holdings · 264

Export CSV
Showing 1–50 of 264 holdings by value · page 1 of 6
Holding Balance Value % of Fund Open
Repurchase Agreement
9,343,385 $9,343,385 9.22%
Repurchase Agreement
6,212,617 $6,212,617 6.13%
—
2,513 $5,641,993 5.57%
—
2,639 $5,277,334 5.21%
ProShares GENIUS Money Market ETF
50,000 $5,006,000 4.94%
Repurchase Agreement
3,727,570 $3,727,570 3.68%
Repurchase Agreement
1,988,037 $1,988,037 1.96%
Repurchase Agreement
1,242,523 $1,242,523 1.23%
Royalty Pharma plc
15,850 $973,349 0.96%
—
4,721 $964,150 0.95%
Roivant Sciences Ltd.
25,709 $890,560 0.88%
—
5,625 $681,565 0.67%
Ascendis Pharma A/S
2,202 $579,214 0.57%
Jazz Pharmaceuticals plc
2,242 $562,025 0.55%
INVESCO GOVT AND AGCY LEX
542,617 $542,617 0.54%
—
4,640 $415,756 0.41%

Showing the top 50 of 264 holdings. Create a free account to see every holding and download the CSV.